Editorial: Neurocognitive disorders and depression—Complex interrelationships DOI Creative Commons
Katarzyna Broczek,

Marie-Christine Gély-Nargeot,

Pietro Gareri

et al.

Frontiers in Psychology, Journal Year: 2023, Volume and Issue: 14

Published: Jan. 30, 2023

EDITORIAL article Front. Psychol., 30 January 2023Sec. Psychology for Clinical Settings Volume 14 - 2023 | https://doi.org/10.3389/fpsyg.2023.1088086

Language: Английский

Arketamine for cognitive impairment in psychiatric disorders DOI Creative Commons
Kenji Hashimoto

European Archives of Psychiatry and Clinical Neuroscience, Journal Year: 2023, Volume and Issue: 273(7), P. 1513 - 1525

Published: Feb. 14, 2023

Cognitive impairment has been observed in patients with various psychiatric disorders, including schizophrenia, major depressive disorder (MDD), and bipolar (BD). Although modern therapeutic drugs can improve certain symptoms (i.e., psychosis, depression) these patients, have not found to cognitive impairment. The N-methyl-D-aspartate receptor antagonist (R,S)-ketamine attracted attention as a rapidly acting antidepressant. In addition its robust antidepressant effects, suggested MDD BD, despite causing healthy control subjects. is racemic mixture of equal amounts (R)-ketamine (or arketamine) (S)-ketamine esketamine). Arketamine more potent antidepressant-like actions than esketamine rodents. Interestingly, arketamine, but esketamine, phencyclidine-induced deficits mice. Furthermore, arketamine ameliorate rodent offspring after maternal immune activation. the current article, it proposed that potential for treating disorders. Additionally, role gut-microbiome-brain axis disorders discussed.

Language: Английский

Citations

33

Multimorbidity, healthy lifestyle, and the risk of cognitive impairment in Chinese older adults: a longitudinal cohort study DOI Creative Commons
Xiaolong Xing, Xueli Yang,

Jinqian Chen

et al.

BMC Public Health, Journal Year: 2024, Volume and Issue: 24(1)

Published: Jan. 2, 2024

Evidence on the association between multimorbidity and cognitive impairment in Chinese older population is limited. In addition, whether a healthy lifestyle can protect function multimorbid remains unknown.

Language: Английский

Citations

14

Probiotics as modulators of gut-brain axis for cognitive development DOI Creative Commons
Akash Kumar, Bhagavathi Sundaram Sivamaruthi, Swarnima Dey

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Feb. 20, 2024

Various microbial communities reside in the gastrointestinal tract of humans and play an important role immunity, digestion, drug metabolism, intestinal integrity, protection from pathogens. Recent studies have revealed that gut microbiota (GM) is involved communication with brain, through a bidirectional network known as gut-brain axis. This involves humoral, immunological, endocrine, neural pathways. Gut dysbiosis negatively impacts these pathways, leading to neurological complications cognitive deficits. Both pre-clinical clinical demonstrated probiotics can restore healthy GM, reduce pH, inflammation pathogenic microbes gut. Additionally, improve cell-to-cell signaling increase blood-brain-derived neurotrophic factors. Probiotics emerge potential approach for preventing managing Despite promising findings, safety concerns possible risks probiotic usage must be closely monitored addressed. review article provides brief overview significance health.

Language: Английский

Citations

13

Regulatory mechanisms of the probiotic-targeted gut–liver axis for the alleviation of alcohol-related liver disease: a review DOI

Feiyu Yang,

Xiangfei Li, Jing Sun

et al.

Critical Reviews in Food Science and Nutrition, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 22

Published: Feb. 5, 2025

Alcohol abuse-triggered alcohol-related liver disease (ALD) has become as a global public health concern that substantially affects the well-being and clinical status of patients. Although modern medicine provides various treatments for ALD, their effectiveness is limited can lead to adverse side effects. Probiotics have been employed prevent, alleviate, even treat with promising results. However, few comprehensive reviews are available on how they mitigate ALD by targeting gut-liver axis. This review systematically clarifies specific mediators axis in healthy states. It also describes alterations observed ALD. Furthermore, this thoroughly summarizes underlying mechanisms through which probiotics act relieve discusses current challenges faced research applications. Finally, we discuss future prospects using improves our understanding supports development application target therapeutic use.

Language: Английский

Citations

1

Cognitive functioning in children and adolescents with depression: A systematic review and meta-analysis DOI
Anett Schumacher, Susan C. Campisi,

Anisa F. Khalfan

et al.

European Neuropsychopharmacology, Journal Year: 2023, Volume and Issue: 79, P. 49 - 58

Published: Dec. 20, 2023

Language: Английский

Citations

17

Cognition and gut microbiota in schizophrenia spectrum and mood disorders: A systematic review DOI
Stéphanie Frileux,

M. Boltri,

Joël Doré

et al.

Neuroscience & Biobehavioral Reviews, Journal Year: 2024, Volume and Issue: 162, P. 105722 - 105722

Published: May 15, 2024

Language: Английский

Citations

6

Cognitive impairment and depression precede increased HDL-C levels in middle-aged and older Chinese adults: cross-lagged panel analyses DOI Creative Commons
Yihui Liu,

Mu-Tong Chen,

Yong‐Yi He

et al.

Lipids in Health and Disease, Journal Year: 2024, Volume and Issue: 23(1)

Published: Sept. 9, 2024

Language: Английский

Citations

6

The preventive effects of Saccharomyces boulardii against oxidative stress induced by lipopolysaccharide in rat brain DOI Creative Commons
Fatemeh Babaei,

Ava Navidi-Moghaddam,

Ariyan Naderi

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 10(9), P. e30426 - e30426

Published: April 26, 2024

The brain is sensitive to oxidative stress, which can trigger microglial activation and neuroinflammation. Antioxidant therapies may provide neuroprotection against stress. In recent years antioxidant effects of probiotics their possible mechanisms in stress-related models have been determined. the current study, for first time, we assessed

Language: Английский

Citations

5

The Impact of Microbiota on Neurological Disorders: Mechanisms and Therapeutic Implications DOI Open Access
Giuseppe Merra,

Giada La Placa,

Marcello Covino

et al.

OBM Neurobiology, Journal Year: 2025, Volume and Issue: 09(01), P. 1 - 12

Published: Feb. 28, 2025

Interactions in the gut-brain crosstalk have led to development of an entirely new concept: "microbiota-gut-brain axis". Microbiota has gained considerable attention relation disorders a more neurological nature, such as neurodevelopmental and neuropsychiatric illnesses like autism spectrum disorder, anxiety, mood disorders. This review aims summarize recent trends insights into role consequences gut microbiota brain health pediatric Dysbiosis may be associated with increased risk diseases that lead different disruptions conditions, including mental issues. During dysbiosis, neuropsychological stress hormones usually affect oxytocin GABA neurons are significantly reduced. Current studies report major depression, cognitive dysfunction closely dysbiosis. In last few years, handful clinical emerged, illustrating potential for bidirectional relationship interactions humans. Perhaps some most crucial investigations demonstrating overlapping relationships human axis come from trials focusing on modulating noting significant correlates. A field is emerging gene-editing technology could represent tool improve microbial characteristics. approach particularly relevant neurodegenerative brain-gut linked loss species and/or high pathobiont load.

Language: Английский

Citations

0

Higher dietary vitamin D intake influences brain and mental function in elderly Americans: a cross-sectional analysis DOI Creative Commons

Huizhen Chen,

Xing Pang,

Yuelong Huang

et al.

Frontiers in Nutrition, Journal Year: 2025, Volume and Issue: 12

Published: April 9, 2025

Vitamin D is known to have a potential impact on cognitive function and mental health. This study aims assess the association between dietary vitamin intake performance, as well depression, in an elderly U.S. population. Data from National Health Nutrition Examination Survey (NHANES) 2013-2014 were analyzed. A total of 1,344 participants categorized into three tertiles based their (D2 + D3). Cognitive was measured using Consortium Establish Registry for Alzheimer's Disease (CERAD) test, Digit Symbol Substitution Test (DSST), Animal Fluency Test, while depression assessed through Patient Questionnaire-9 (PHQ-9). Adjustments made confounding variables, including age, sex, race, education, physical activity level, other factors. After adjustment confounders, individuals 3rd tertile (≥4.9 mcg/day) had significantly reduced odds low performance CERAD test (OR: 0.77, 95% CI: 0.57-0.98; p = 0.031) 0.63, 0.49-0.85; 0.013) compared 1st (≤2.4 mcg/day). Similarly, lower (PHQ-9 score > 4) after 0.68, 0.48-0.99; 0.046). Our findings suggest that associated with improved depressive symptoms individuals. However, further longitudinal studies are needed establish causality explore underlying mechanisms.

Language: Английский

Citations

0